Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.-Reference-Cited by-同舟云学术

Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.

Published:1988-10 Issue:4 Volume:26 Page:435-443
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Davis SS,Washington N,Parr GD,Short AH,John VA,Lloyd P,Walker SM

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1988.tb03403.x/fullpdf

Reference21 articles.

1. Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing;Antonin;Br. J. clin. Pharmac.,1985

2. Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man;Brunner;Eur. J. clin. Pharmac.,1975

3. Transit of pharmaceutical dosage forms through the small intestine;Davis;Gut,1986

4. Gastric emptying of large singleunit dosage forms;Davis;J. Pharm. Pharmac.,1988

5. Simplified method for the determination of oxprenolol and other β-receptor blocking agents in biological fluids by gas-liquid chromatography;Degen;J. Chromatogr.,1976

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Site-Directed Drug Delivery and Influence on PK;Drug Delivery Approaches;2021-08-06

2. Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets;Hydrophilic Matrix Tablets for Oral Controlled Release;2014

3. A nanofibrous sheet-based system for linear delivery of nifedipine;Journal of Controlled Release;2011-02

4. Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder;CNS Drugs;2010-12

5. Oral osmotically driven systems: 30 years of development and clinical use;European Journal of Pharmaceutics and Biopharmaceutics;2009-11